GlaxoSmithKline | Zobowiązania Handlowe



Trade Creditors Zmiana Data
AbbVie 2.94B 2.66B 2024-12
Alcon AG USD 842M 69M 2025-03
Almirall EUR 249.42M 67.09M 2024-12
Amgen USD 2.41B 498M 2025-03
AstraZeneca 22.54B 79M 2025-03
Bayer EUR 6.59B 931M 2025-03
Biogen USD 391.5M 32.7M 2025-03
Bristol-Myers Squibb USD 4B 400M 2025-03
Eli Lilly USD 3.44B 213.4M 2025-03
Fresenius EUR 1.26B 103M 2025-03
Fresenius Medical Care EUR 769M 135M 2025-03
Galapagos EUR 168.94M 70.06M 2025-03
Gilead Sciences USD 833M 70M 2024-12
GlaxoSmithKline 15.15B 186M 2025-03
Glaxosmithkline 3.46B 10.01B 2024-12
GRIFOLS EUR 852.3M 25.42M 2024-12
Hikma Pharmaceutical USD 541M 232M 2024-06
Lonza CHF 468M 9M 2023-12
Merck EUR 1.5B 448M 2024-12
Merck USD 3.78B 295M 2025-03
Novartis USD 4.57B 485M 2024-12
Novo Nordisk 19.58B 4.5B 2025-03
Orion EUR 89.7M 2.6M 2025-03
Pfizer USD 5.24B 393M 2025-03
Philips EUR 1.83B 0 2025-03
Recordati EUR 334.45M 57.54M 2025-03
Regeneron Pharmaceuticals USD 705.5M 4.18B 2025-03
Roche Holding 4.35B 828M 2024-12
Sanofi 21.62B 14.07B 2025-03
Smith & Nephew USD 1.13B 104M 2024-12
UCB 750M 1.66B 2024-12



GlaxoSmithKline Zobowiązania Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.